Authors: GOLDBERG RB EINHORN D LUCAS CF RENDELL MS DAMSBO P HUANG WC STRANGE P BRODOWS RG

Citation: Rb. Goldberg et al., A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF REPAGLINIDE IN THE TREATMENTOF TYPE-2 DIABETES, Diabetes care, 21(11), 1998, pp. 1897-1903

Authors: BONER G VANDYK DJ TAN MH TAN J EKSTRAND A KOIVISTO VA GROOP LC GROOP PH LUCAS A ROMERO R SALINAS I SANMARTI A ESCOBAR F ESCOBARJIMENEZ F CAMPOSPASTOR MM MUGOZ M GOMEZ M MANGILI R POZZA G SPOTTI D HANSEN KW CHRISTIANSEN JS KLEIN F MOGENSEN CE ZIEKENHUIS M VANDOORN LG SPOOREN PFMJ CRUICKSHANK JK JERVELL J PAUS PN BARNES DJ COLLINS A VIBERTI GC WILLIAMS G NELSTROP GA AMOROSA L ANOLIK JR ARONOFF SL EUBANK B BAILIE M PELLETIER L BLEVINS T CHARLES MA PERRY M CLARKE D TOMKEY D EINHORN D HUMPHRIES D GARBER AJ HAAG B WILLIAMS E HOY W WATKINS M KAHKONEN D KRUGER D KILO C LAFFEL L GOLDEN E LODEWICK P LOVINSKY D MASON J JOHNSON S MCGILL J SCHMIDT L ORLANDER P SORENSON K RASKIN P HELLENBRAND D ROSENBLATT S SCHWARTZ S AUFIERI J SHEEHAN JP ULCHAKER M SKYLER JS AGRAMONTE R STARR J GAGLIASTRE D TAYLOR T DAWN K WARD WK RIGDON M COOPER M GANS DJ

Citation: G. Boner et al., CAPTOPRIL REDUCES THE RISK OF NEPHROPATHY IN IDDM PATIENTS WITH MICROALBUMINURIA, Diabetologia, 39(5), 1996, pp. 587-593

Authors: SKYLER JS LORENZ TJ SCHWARTZ S EISENBARTH GS EINHORN D PALMER JP MARKS JB GREENBAUM C SARIA EA BYERS V

Citation: Js. Skyler et al., EFFECTS OF AN ANTI-CD5 IMMUNOCONJUGATE (CD5-PLUS) IN RECENT-ONSET TYPE-I DIABETES-MELLITUS - A PRELIMINARY INVESTIGATION, Journal of diabetes and its complications, 7(4), 1993, pp. 224-232